Example Image
Civitas Outlook
Topic
Economic Dynamism
Published on
Feb 5, 2025
Contributors
Richard Epstein
Benjamin Flowers
"Research Chemist in Lab" U.S. Department of Agriculture, Public Domain, via Wikimedia Commons.

Why Failure-to-Market Claims Are Preempted Under Federal Law

Contributors
Richard Epstein
Richard Epstein
Senior Research Fellow
Richard Epstein
Benjamin Flowers
Benjamin Flowers
Benjamin Flowers
Summary
This short white paper addresses preemption arguments relevant to “failure to market” claims, which cover those cases in which plaintiffs allege that drug companies may be held liable for failing to bring to market, as quickly as possible, drugs that present (allegedly) fewer side effects than other, FDA-approved drugs already on the market.
Summary
This short white paper addresses preemption arguments relevant to “failure to market” claims, which cover those cases in which plaintiffs allege that drug companies may be held liable for failing to bring to market, as quickly as possible, drugs that present (allegedly) fewer side effects than other, FDA-approved drugs already on the market.
Listen to this article

A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The claim rested on factual premises contradicted by all publicly available information, the acceptance of which could seriously disrupt the FDA approval process. This disruption gives rise to an issue the parties did not raise on appeal and that the appeals court never addressed, notwithstanding the complex, comprehensive statutes governing drug approval: these state tort law claims are preempted under theories of both field and conflict (including obstacle) preemption. This White Paper explains why it is imperative for the federal government and private parties to advance these preemption arguments, and why the courts should accept them.

Read the Issue Brief

This white paper was originally published by the Pacific Research Institute's Center for Medical Economics and Innovation.

Keep Reading & Download PDF
10:13
1x
10:13
More articles

New York’s Surging New Leftist Tide Is a Chilling Warning to the West

Politics
Jun 24, 2025

Trump’s Iran Ceasefire Depends on American Oil

Politics
Jun 24, 2025
View all

Join the newsletter

Receive new publications, news, and updates from the Civitas Institute.

Sign up
More on

Economic Dynamism

Defending Technological Dynamism & the Freedom to Innovate in the Age of AI

Human flourishing, economic growth, and geopolitical resilience requires innovation—especially in artificial intelligence.

Adam Thierer
Economic Dynamism
Jun 6, 2025
Partisan Trust in the Federal Reserve

This paper examines partisanship in public perceptions of the Federal Reserve.

Carola Binder, Cody Couture, Abhiprerna Smit
Economic Dynamism
Apr 22, 2025
The American Dream Is Not a Coin Flip, and Wages Have Not Stagnated

This paper challenges the prevailing narrative that stagnant wages are causing the American dream to fade. It contrasts subjective public opinion with revised objective intergenerational mobility measures.

Scott Winship
Economic Dynamism
Mar 6, 2025
Political Economy and the Rise of Commercial Humanism

Western attitudes toward commerce have transformed from early moral condemnation to a modern appreciation that sees trade as socially beneficial.

Erik Matson
Economic Dynamism
Feb 28, 2025
No items found.
It’s Not Easy, but We Can All Learn to Think like Adam Smith

To truly understand what a dynamic economy requires, we would do well to recover the 18th-century sensibility that understood dynamism as a social and cultural phenomenon as much as an economic one.

Ryan Streeter
Economic Dynamism
Jun 18, 2025
Locked Out of the Dream: Regulation Making Homes Unaffordable Around the World

The first in a two-part series on the global housing crisis.

Joel Kotkin
Economic Dynamism
Jun 5, 2025
A Most Favored National Policy for Pharma Drugs Makes Sense

"Most favored nation" pricing can help make America's pharmaceutical marketplace more competitive.

Dirk Mateer
Economic Dynamism
May 19, 2025
The High Cost of California’s Green Energy Policies

California can only prosper if it can develop affordable, reliable energy from all sources, including the state’s fossil fuel supplies.

Joel Kotkin
Economic Dynamism
May 7, 2025

Richard Epstein: Law and Economics of Public Sector Unions

Economic Dynamism
Jun 19, 2025
1:05

Can the U.S. Defense Industrial Base Meet Today’s Challenges?

Economic Dynamism
May 13, 2025
1:05

Virginia Postrel and Adam Thierer on Big Trends and Big Ideas in Dynamism

Economic Dynamism
Apr 29, 2025
1:05

Joel Mokyr on American Dynamism vs. Techno-pessimism

Economic Dynamism
Apr 29, 2025
1:05

Arthur Herman on Mobility, Markets, and Natural Law

Economic Dynamism
Apr 29, 2025
1:05
No items found.
No items found.
American Aspiration – a Blueprint

We need to refocus on what prosperity produces and requires at the level of ordinary, individual people trying to make their way to that better version of themselves that only they can achieve. 

Ryan Streeter
Economic Dynamism
Jun 20, 2025
Today’s Upside-Down Preference for Wind over Natural Gas

Trump is right to push for his safe pipeline; Hochul should abandon her dangerous wind farms.

Richard Epstein
Economic Dynamism
Jun 19, 2025
The Worst Thing about Trump’s Approach to Trade

The precedents set by President Trump will create serious problems for future interactions between the business sector and the state.

Paul Mueller
Economic Dynamism
Jun 18, 2025
Looking West: Trade and America’s Future in the Asia-Pacific

In what world does it make sense for the United States to allow Beijing to slowly turn the Asia-Pacific rim into a Chinese-dominated economic lake from which America is excluded?

Samuel Gregg
Economic Dynamism
Jun 18, 2025
No items found.